Research Article

Factors Associated with Vitamin D Deficiency and Inadequacy among Women of Childbearing Age in the United States

Table 1

Unadjusted and adjusted prevalence ratios (with 95% confidence intervals)* for vitamin D deficiency and inadequacy among women aged 20–44 years, NHANES 2003–2006, 𝑁 = 1,814.

CharacteristicVitamin D deficiencyVitamin D inadequacy
𝑁 UnadjustedAdjustedUnadjustedAdjusted

Demographic
 Age (yrs)
  20–276511.001.001.001.00
  28–345400.98 (0.67–1.43)1.02 (0.78–1.34)0.94 (0.76–1.16)0.92 (0.78–1.09)
  35–446231.17 (0.83–1.66)1.19 (0.81–1.74)1.09 (0.86–1.39)1.10 (0.88–1.38)
 Race/ethnicity
  Non-Hispanic white8561.001.001.001.00
  Non-Hispanic black37012.82 (7.31–22.47)8.27 (5.06–13.50)3.21 (2.50–4.13)2.78 (2.14–3.61)
  Mexican American417 5.47 (2.85–10.51)4.14 (2.20–7.78)2.48 (1.93–3.18)1.78 (1.36–2.33)
  Other171 5.36 (2.72–10.56)5.44 (3.03–9.78)2.48 (1.89–3.24)2.25 (1.74–2.92)
 Education
   <High school diploma3931.001.001.001.00
  High school graduate3830.69 (0.47–1.02)1.06 (0.74–1.52)0.78 (0.57–1.06)1.03 (0.78–1.36)
  >High school diploma1,0380.39 (0.29–0.55)1.00 (0.75–1.34)0.53 (0.42–0.66)0.86 (0.67–1.10)

Pregnancy status
 Currently pregnant4350.73 (0.37–1.45)0.72 (0.41–1.26)0.66 (0.45–0.96)0.70 (0.49–1.00)
 With a history of pregnancy1,0341.38 (0.99–1.92)0.82 (0.57–1.16)1.21 (0.93–1.59)0.89 (0.71–1.11)
 Never pregnant3451.001.001.001.00

Diet and supplementation
 Milk consumption
  Never2221.001.001.001.00
  >0 to <1 time/day7300.54 (0.39–0.76)0.77 (0.57–1.06)0.94 (0.67–1.32)0.87 (0.64–1.18)
  β‰₯1 time/day8620.20 (0.13–0.34)0.34 (0.23–0.51)0.59 (0.42–0.83)0.56 (0.40–0.77)
 Fish consumption
  Never5731.001.001.001.00
   >0 to <2 times/wk1,1340.79 (0.52–1.19)0.75 (0.56–1.01)1.00 (0.83–1.21)1.01 (0.82–1.24)
  β‰₯2 times/wk1070.67 (0.33–1.34)0.62 (0.31–1.23)0.64 (0.40–1.03)0.71 (0.48–1.05)
 Dietary supplement use
  Yes9430.30 (0.22–0.40)0.57 (0.42–0.78)0.55 (0.46–0.66)0.69 (0.58–0.81)
   No8711.001.001.001.00

Examination period
 Nov. 1-Apr. 318571.001.001.001.00
 May 1-Oct. 319570.37 (0.23–0.60)0.51 (0.37–0.71)0.52 (0.40–0.68)0.58 (0.47–0.73)

Body mass index (kg/m2)**
 <25.07851.001.001.001.00
 25.0–29.94551.32 (0.93–1.86)1.06 (0.77–1.46)1.48 (1.13–1.93)1.25 (0.97–1.60)
 β‰₯30.05743.37 (2.41–4.72)1.74 (1.27–2.38)2.11 (1.58–2.81)1.94 (1.54–2.45)

Chronic condition
 Hypertension
  Yes1202.44 (1.72–3.46)0.95 (0.67–1.34)1.39 (0.99–1.96)0.92 (0.64–1.31)
  No1,6941.001.001.001.00
 Diabetes
  Yes442.06 (1.13–3.74)1.52 (1.01–2.32)1.59 (1.08–2.34)1.02 (0.68–1.54)
   No1,7701.001.001.001.00
 Cardiovascular disease
  Yes323.12 (1.90–5.14)2.30 (1.31–4.04)1.51 (0.97–2.33)1.50 (0.96–2.34)
  No1,7821.001.001.001.00
 Asthma
  Yes1711.35 (0.94–1.92)1.00 (0.73–1.37)0.86 (0.59–1.26)0.89 (0.67–1.19)
   No1,6431.001.001.001.00

Lifestyle-related behavior
 Current Smoking
   Yes3851.25 (0.85–1.85)1.40 (1.06–1.85)1.06 (0.86–1.31)1.08 (0.89–1.31)
  No1,4291.001.001.001.00
 Physical activity
  Yes1,5580.39 (0.28–0.54)0.87 (0.61–1.24)0.77 (0.60–0.99)1.19 (0.92–1.54)
  No2561.001.001.001.00
 Any alcohol use
  Yes1,2030.52 (0.39–0.71)0.82 (0.61–1.09)0.69 (0.56–0.84)0.90 (0.75–1.07)
   No6111.001.001.001.00

Healthcare access
 Insurance coverage
  Yes1,3880.59 (0.41–0.84)1.01 (0.70–1.46)0.65 (0.52–0.80)0.94 (0.77–1.15)
  No4261.001.001.001.00
  Healthcare visit
  Yes1,6090.61 (0.42–0.87)0.87 (0.64–1.19)0.70 (0.54–0.90)0.84 (0.64–1.09)
  No2051.001.001.001.00

*Prevalence ratios and 95% confidence intervals were estimated using log-linear regression models without and with adjustment for all other variables listed in the table; women with serum 25(OH)D β‰₯20 ng/mL was used as the referent.
**Self-reported prepregnant weight and height were used to calculate body mass index (BMI) for pregnant women, and measured weight and height were used to calculate BMI for nonpregnant women.